Sai Life Sciences IPO Timeline : Issue Dates, Listing Date, and Allotment Dates
For the Sai Life Sciences IPO, the company is issuing shares at a pre-issue EPS of ₹4.53 and a post-issue EPS of ₹0.40. The pre-issue P/E ratio is 121.19x, while the post-issue P/E ratio is 136.21x against the Industry P/E ratio is 95.33x. The company's ROCE for FY24 is 10.26% and RoE for FY24 is 8.49%. These metrics suggest that the IPO is fully priced.
Key Performance Indicator |
|||||||||||
KPI | Values | ||||||||||
EPS Pre IPO (Rs.) | ₹4.53 | ||||||||||
EPS Post IPO (Rs.) | ₹0.40 | ||||||||||
P/E Pre IPO | 121.19 | ||||||||||
P/E Post IPO | 136.21 | ||||||||||
ROE | 8.49% | ||||||||||
ROCE | 10.26% | ||||||||||
P/BV | 5.74 | ||||||||||
Debt/Equity | 0.75 | ||||||||||
RoNW | 8.50% |
Equity Investment with CA Abhay
FNO Stocks with CA Abhay
Stock Market Masterclass
Option Trading with CA Abhay
Equity Trading with CA Abhay
Option Trading with CA Abhay
Equity Investment with CA Abhay
FNO Stocks with CA Abhay
Equity Trading with CA Abhay
Stock Market Masterclass
Copyright @2020 Design & Developed by Info Web Software